Cited by 20Health disparities and outcomesAging, Health, and DisabilityAging and Gerontology Research

Commentary: Life course epidemiology: the past two decades and future directions

Open access
Newman, Anne B·2016·International Journal of Epidemiology

Abstract

Life course epidemiology has the great potential to help us understand why and how we age. Ultimately, the goal of such research is to identify the critical time points where interventions could ameliorate the disabling consequences of ageing. Epidemiological studies have assessed risk for disability in late life or have focused on longevity. It is now clear that we need to look back to earlier points in life to understand the origins of these important outcomes. The review by Ben-Shlomo, Cooper and Kuh1 provides an important perspective on how life course and ageing research are linked and can inform each other. Ageing is most easily recognized in the very old with a stereotypical pattern of slowing gait, greying hair and loss of function in many organ systems. For being so universally recognizable, it is perhaps surprising that ageing is so difficult to measure. Genetic and environmental manipulations such as caloric restriction clearly promote longevity in animal models.2 In these models, researchers are advocating for more emphasis on measuring health span and adopting measures of the signs of ageing such as motility or mobility.3 In humans, measures of physical and cognitive performance are often used to define the degree or rate of ageing.4 Changes in these domains are often only apparent very late in life.5 This lack of sensitivity results in a ‘ceiling effect’, where we cannot detect better than usual function. Since most younger-old and middle-aged adults function in this usual range, it is not possible to use basic measures of physical and cognitive function to understand ageing earlier in life. Biomarkers of the process of ageing have long been sought, but no single measure has been found that can compete with chronological age itself in prediction mortality or health span.6 Measures that are informative about the ageing process across the lifespan are needed to advance life course epidemiology to study ageing. One important question for life course epidemiology of ageing is: ‘When does ageing begin’? This would reveal opportunities for delaying its start or maximizing development before its onset. Some would argue that ageing begins at conception, or even before conception,7 in that measures linked to ageing like telomere length8 and mitochondrial heteroplasmy9 are inherited. Certainly there is much to learn from the field of the developmental origins of health and disease (DOHaD). Current studies are limited in design by the selection of measures chosen for purposes other than ageing, yet are currently most valuable to address questions of risk for disease, disability and death from the vantage point of early life determinants. Looking further down the line, others would define the start of ageing as the period starting after the achievement of peak development. After this point, there can be stability or the earliest signs of decline. Endurance in physical activity, particularly maximal oxygen consumption, is well known to begin to decline around age 40.10 This is recognized in the age of peak performance of marathon runners as well as in physiological studies that assess volume of oxygen uptake (VO2) serially. Many epidemiological studies of ageing have started only at age 65 or 70, and thus have missed the opportunity to understand the roles of peak development and early decline as risk factors for future function and ageing. Conversely, many of the ongoing studies in middle age or younger have not included age-sensitive measures. Promising measures include VO2 max,10 bone density11 and muscle strength,12 all of which have been shown to have age-related declines well before age 65. The variable course of ageing is an important challenge in doing life course research. Variability itself is prognostic for poor health outcomes.13 Increasing the frequency of assessment can aid in understanding this. Perhaps the field could borrow the approach of using frequent ’burst’ assessments from psychology14 which has been shown to capture response to stress and recovery. Potentially, the process of ageing might be revealed earlier by the use of tests of vulnerability or resilience to stressors. Such an approach is being adopted in the development of drugs in model organisms. Testing endurance with VO2 max might be considered a stress test of capacity to respond to a stressor, reflecting vulnerability or resilience due to ageing. As noted by Ben-Shlomo, Copper and Kuh,1 the assessment of response to stressors can be considered in the context of the sensitive periods in the life course. Ageing and age-related chronic disease are intrinsically linked in that age is a risk factor for disease and multimorbidity is a major contributor to age-related decline. It is not certain whether these can be disentangled in longitudinal studies. The previous emphasis of ageing studies on disease outcomes has considered many diseases such as osteoporosis and cardiovascular disease (CVD) individually, limiting our ability to

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ije/dyw102

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • High levels of age-associated pro-inflammatory markers are detected in most older individuals even without risk factors and clinically active diseases.

    “High levels of age-associated pro-inflammatory markers are detected in the majority of older individuals, even in the absence of risk factors and clinically active diseases3,5–7.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 18 references couldn’t be matched to a known paper.

Research works printed but not linked: 12

  1. Cooper R, Kuh D, Cooper C et al.; FALCon and HALCyon Study Teams. Objective measures of physical capability and sub- sequent health: a systematic review. Age Ageing 2011;40:14-23.
  2. Cooper R, Kuh D, Hardy R; Mortality Review Group, FALCon and HALCyon Study Teams. Objectively measured physical cap- ability levels and mortality: systematic review and meta-analysis. BMJ 2010;341:c4467.
  3. Dodds RM, Syddall HE, Cooper R et al. Grip strength across the life course: normative data from twelve British studies. PLoS One 2014;9:e113637.
  4. Inskip HM, Godfrey KM, Robinson SM, Law CM, Barker DJ, Cooper C ; SWS Study Group. Cohort profile: The Southampton Women's Survey. Int J Epidemiol 2006;35:42-48.
  5. Simmonds SJ, Syddall HE, Westbury LD, Dodds RM, Cooper C, Sayer AA. Grip strength among community-dwelling older people predicts hospital admission during the following decade. Age Ageing 2015;44:954-59.
  6. Kerr A, Syddall HE, Cooper C, Turner GF, Briggs RS, Sayer AA. Does admission grip strength predict length of stay in hospital- ised older patients? Age Ageing 2006;35:82-84.
  7. Gill TM, Gahbauer EA, Han L, Allore HG. Trajectories of dis- ability in the last year of life. N Engl J Med 2010;362:1173-80.
  8. Gill TM, Hardy SE, Williams CS. Underestimation of disability in community-living older persons. J Am Geriatr Soc 2002;50: 1492-97.
  9. Gill TM, Kurland B. The burden and patterns of disability in activities of daily living among community-living older persons. J Gerontol A Biol Sci Med Sci 2003;58:70-75.
  10. Gill TM, Williams CS, Mendes de Leon CF, Tinetti ME. The role of change in physical performance in determining risk for depend- ence in activities of daily living among nondisabled community- living elderly persons. J Clin Epidemiol 1997;50:765-72.
  11. Gill TM, Baker DI, Gottschalk M, Peduzzi PN, Allore H, Byers A. A program to prevent functional decline in physically frail, elderly persons who live at home. N Engl J Med 2002;347:1068-74.
  12. Denison HJ, Syddall HE, Dodds R et al. The effects of aerobic exer- cise on sarcopenia and physical performance among community dwelling older people from the Hertfordshire Cohort Study: a rand- omised controlled trial. Age Ageing 2013;42(Suppl 2): ii26-ii27. International Journal of Epidemiology, 2016, 1013-1015 doi: 10.1093/ije/dyw102 References

Cited by

Sorted by citations

Authors
Newman, A. B.
Affiliations
University of Pittsburgh (US)
Corresponding author
Newman, Anne B
Venue
International Journal of Epidemiology
Published
2016-08-01
Volume
45
Issue
4
Pages
1013-1015
ISSN
  • 0300-5771 (ISSN-L)
  • 1464-3685
OpenAlex
W2531561637
Cited by
20
References
18
Citations by year
2025: 3 · 2024: 2 · 2022: 2 · 2021: 2 · 2020: 3 · 2019: 1 · 2018: 3 · 2017: 3 · 2016: 1
Type
journal article
Language
en
Open access
Licence
public-domain
Locations
  • International Journal of Epidemiology (publishedVersion, public-domain)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
  • National Institute of Aging (NIA) (R01 AG023629)
  • Exceptional Survival: Trajectories to Functional Aging (P30 AG024827)
Topics
  • Social Sciences › Health › Health disparities and outcomes
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Aging, Health, and Disability
  • Social Sciences › Psychology › Neuropsychology and Physiological Psychology › Aging and Gerontology Research
Keywords
life course epidemiology, aging, healthspan, aging biomarkers, developmental origins of health and disease, early life factors, telomere length, mitochondrial heteroplasmy, longevity, middle-aged and older adults, mortality risk
MeSH terms
Forecasting, Humans

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review